ASSOCIATION BETWEEN POLYMORPHISMS OF RFC1 GENE AND HIGH-DOSE METHOTREXATE THERAPY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
Yang, J. [1 ]
Jiang, H. [1 ]
Li, H. [1 ]
机构：
[1] Shanghai Childrens Hosp, Shanghai 200040, Peoples R China
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-022
引用
收藏
页码：S172 / S172
页数：1
相关论文
共 50 条
  • [31] Risk factors for delayed elimination of high-dose methotrexate in childhood acute lymphoblastic leukemia and lymphoma
    Takaaki Nakano
    Ryoji Kobayashi
    Satoru Matsushima
    Daiki Hori
    Masato Yanagi
    Daisuke Suzuki
    Kunihiko Kobayashi
    [J]. International Journal of Hematology, 2021, 113 : 744 - 750
  • [32] Risk factors for delayed elimination of high-dose methotrexate in childhood acute lymphoblastic leukemia and lymphoma
    Nakano, Takaaki
    Kobayashi, Ryoji
    Matsushima, Satoru
    Hori, Daiki
    Yanagi, Masato
    Suzuki, Daisuke
    Kobayashi, Kunihiko
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (05) : 744 - 750
  • [33] Genetic polymorphisms in the folate pathway and risk of childhood acute lymphoblastic leukemia (ALL): MTHFR, MTHFD1, RFC1 and TS.
    Yeoh, Allen Eng-Juh
    Kham, Shirley Kow-Yin
    Foo, Toon-Chai
    Ariffin, Hany
    Quah, Thuan-Chong
    [J]. BLOOD, 2006, 108 (11) : 644A - 644A
  • [34] Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia
    Liu, Shu-Guang
    Gao, Chao
    Zhang, Rui-Dong
    Zhao, Xiao-Xi
    Cui, Lei
    Li, Wei-Jing
    Chen, Zhen-Ping
    Yue, Zhi-Xia
    Zhang, Yuan-Yuan
    Wu, Min-Yuan
    Wang, Jian-Xiang
    Li, Zhi-Gang
    Zheng, Hu-Yong
    [J]. ONCOTARGET, 2017, 8 (23) : 37761 - 37772
  • [35] HIGH-DOSE METHOTREXATE IN ACUTE LYMPHOCYTIC-LEUKEMIA IN CHILDHOOD
    MOE, PJ
    [J]. PEDIATRIC RESEARCH, 1979, 13 (08) : 951 - 951
  • [36] Pharmacokinetics of High-Dose Methotrexate in Infants Treated for Acute Lymphoblastic Leukemia
    Lonnerholm, Gudmar
    Valsecchi, Maria Grazia
    De Lorenzo, Paola
    Schrappe, Martin
    Hovi, Liisa
    Campbell, Myriam
    Mann, Georg
    Janka-Schaub, Gritta
    Li, Chi-Kong
    Stary, Jan
    Hann, Ian
    Pieters, Rob
    [J]. PEDIATRIC BLOOD & CANCER, 2009, 52 (05) : 596 - 601
  • [37] Systematic review: genetic polymorphisms in the pharmacokinetics of high-dose methotrexate in pediatric acute lymphoblastic leukemia patients
    Rahmayanti, Siti Utami
    Amalia, Riezki
    Rusdiana, Taofik
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 94 (02) : 141 - 155
  • [38] Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukemia
    [J]. Yang, L.-H. (yang_lihua@sina.com), 2005, Chinese Medical Association (40)
  • [39] Acute Myelitis That Developed in A Pediatric Patient With Acute Lymphoblastic Leukemia After High-Dose Methotrexate Therapy
    Matsumoto, Kazuki
    Yamashita, Daiki
    Zhu, Yiqing
    Sajiki, Daichi
    Maemura, Ryo
    Sakaguchi, Hirotoshi
    Yoshida, Nao
    Hama, Asahiko
    [J]. PEDIATRIC BLOOD & CANCER, 2019, 66 : S29 - S30
  • [40] Hepatoxicity in a Patient with Acute Lymphoblastic Leukemia Receiving High-Dose Methotrexate
    Kalakota, Neeharika
    Sharma, Ashish
    Bhakta, Dimpal
    Gould, Milena
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S1346 - S1346
12345